TriMas improves continuing earnings and agrees to sell Rapak
TriMas ($TRS) reported third-quarter 2026 sales of $178.7 million, up 7.7%. Operating profit improved to $11.5 million from a $3.2 million loss, while continuing-operations earnings were $0.37 per diluted share, compared with a $0.12 loss. Adjusted EPS increased to $0.50 from $0.17. Cost reductions helped profitability, while interest income on substantial cash holdings and a lower share count also supported per-share earnings. The company signed an agreement to dispose of Rapak, its bag-in-box
0